Table of Content - Human Immunoglobulin (pH4) For Intravenous Injection Market

Human immunoglobulin for intravenous injection (IVIG) has the capacity of proving passive immunity and anti-inflammatory, immunomodulatory effect which results in better treatment and prognosis of severe infections such as COVID-19. The IgG antibodies extracted from recovered patients of COVID-19 are expected to boost the immune response in newly infected patients, leading to a reduction in the treatment duration. Hence, the combination of the immune IgG antibodies as human immunoglobulin for intravenous injection (IVIG) with antiviral drugs can offer short-term and medium-term solutions against COVID-19. Hence, the COVID-19 outbreak is expected to increase demand for human immunoglobulin (pH4) for intravenous injection which is expected to boost the growth of global human immunoglobulin (Ph4) for intravenous injection market.

Market Dynamics

The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to enhance their market presence is expected to propel the market growth during the forecast period. For instance, in January 2020, ADMA Biologics, Inc., a manufacturer, and distributor of plasma-derived biologics, entered a 5-year manufacturing and supply agreement with an undisclosed partner to produce and sell plasma-derived intermediate fractions from ADMA’s Immune Globulin (IG) manufacturing process. Under this agreement, ADMA Biologics, Inc. will maximize the revenue per liter of plasma fractionated in its plant by selling the fractioned plasma to a third party to develop their therapeutic products under their own licensed manufacturing processes.

Key features of the study:

This report provides in-depth analysis of the global human immunoglobulin (pH4) for intravenous injection market and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global human immunoglobulin (pH4) for intravenous injection market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Behring, Bayer AG, Grifols, S.A., Octapharma AG, Shanghai RAAS Blood Products Co., Ltd., Hualan Biological Engineering Inc, China Biologic Products, Inc., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Boya Bio-Pharmaceutical Group Co., Ltd., ADMA Biologics, Inc., and Sinopharm Group Co., Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, disease indication up-gradation, market expansion, and marketing tactics
The global human immunoglobulin (pH4) for intravenous injection market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human immunoglobulin (pH4) for intravenous injection market

Detailed Segmentation:

Global Human Immunoglobulin (pH4) for Intravenous Injection Market, By Type:
- IgG
- IgA
- IgM
Global Human Immunoglobulin (pH4) for Intravenous Injection Market, By Disease Indication :
- COVID-19
- Primary Immunodeficiency Disease
- Immune-mediated Thrombocytopenia
- Kawasaki Disease
- B Chronic lymphocytic Leukemia(B-CLL)
- Others
Global Human Immunoglobulin (pH4) for Intravenous Injection Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Human Immunoglobulin (pH4) for Intravenous Injection Market, By Region:
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Takeda Pharmaceutical Company Limited
- Baxter
- CSL
- Bayer AG
- Grifols, S.A
- Octapharma Brasil Ltda
- Shanghai RAAS Blood Products Co Ltd
- Hualan Biological Engineering, Inc
- Top Bio Group Co, Ltd (A subsidiary of China Biologic Products Holdings, Inc)
- China Resources Boya Bio-pharmaceutical Group Co Ltd
- ADMA Biologics, Inc
- Sinopharm Group Co. Ltd

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Type
  - Market Snapshot, By Disease Indication
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
Global Human Immunoglobulin (pH4) for Intravenous Injection Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Human Immunoglobulin (pH4) for Intravenous Injection Market, By Type, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- IgG
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- IgA
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- IgM
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Global Human Immunoglobulin (pH4) for Intravenous Injection Market, By Disease Indication, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- COVID- 19
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Primary Immunodeficiency Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Immune-mediated Thrombocytopenia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Kawasaki Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- B Chronic lymphocytic Leukemia(B-CLL)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Global Human Immunoglobulin (pH4) for Intravenous Injection Market, By Distribution Channel, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Global Human Immunoglobulin (pH4) for Intravenous Injection Market, By Region, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CSL
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Grifols, S.A
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Octapharma Brasil Ltda
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Shanghai RAAS Blood Products Co Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hualan Biological Engineering, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Top Bio Group Co, Ltd (A subsidiary of China Biologic Products Holdings, Inc)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- China Resources Boya Bio-pharmaceutical Group Co Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ADMA Biologics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sinopharm Group Co. Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 34 market data tables and 33 figures on “Human Immunoglobin pH4 For Intravenous Injection Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount